Shared on 03 Nov 25
Fair value Decreased 1.69%The analyst price target for Merck KGaA has been reduced from EUR 150 to EUR 130, as analysts cite softer growth expectations and recent earnings disappointments. Analyst Commentary Recent street research reflects a cautious tone among analysts regarding Merck KGaA, with a series of price target reductions and rating adjustments.
Shared on 20 Oct 25
Fair value Decreased 1.08%Global Biotechnology And Digital Automation Will Drive Future Healthcare
Analysts have trimmed their fair value estimate for Merck KGaA from €147.53 to €145.94. This change reflects a series of recent price target reductions and persistent concerns regarding growth prospects and limited near-term catalysts.
Shared on 04 Sep 25
Global Biotechnology And Digital Automation Will Drive Future Healthcare
Merck KGaA's consensus price target remains unchanged at €147.53 as analysts adopt a more neutral stance following disappointing Q2 results, lowered guidance, and reduced near-term growth visibility. Analyst Commentary Disappointing Q2 report and weaker-than-expected operational performance.
Shared on 01 May 25
Fair value Decreased 15%Global Biotechnology And Digital Automation Will Drive Future Healthcare
Shared on 23 Apr 25
Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Decreased 2.17%Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 13%Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 11%Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics
Shared on 26 Mar 25
Fair value Decreased 0.81%Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 0.52%Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 11%Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics
AnalystConsensusTarget made no meaningful changes to valuation assumptions.